Sector: MedicalACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)
Headlines
- ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009
Nov 02, 2009 09:00 AM | ACAD
- RidgewaterEquity.com Free Fundamental Sector & Market Research on CNXT, RMBS, ACAD, PWRD, CBAK and NTES
Oct 28, 2009 06:37 AM | ACAD, CNXT, PWRD, RMBS
- ACADIA Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26, 2009
Oct 20, 2009 09:00 AM | ACAD, AGN, BVF
- Market Pulse Breaking News Alert for Wednesday, October 7, 2009: ARYC -- Arrayit Corporation CEO Issues Positive Report to Shareholders and Sales Are Up 41% From a Year Ago!
Oct 07, 2009 08:30 AM | ACAD, HL, UCBH
- (OTC: MNDP) Mundus Group Creates New "Green" Division
Oct 07, 2009 02:30 AM | ACAD
- ACADIA Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference on October 6, 2009
Oct 06, 2009 07:11 AM | ACAD, AGN, BVF
- JMP Securities Healthcare Conference to Be Held in New York
Sep 29, 2009 05:30 PM | ACAD, ALNY, ALTH, ALXA, ANDS, ATHN
- Best OTC Announces Daily Stock Watch
Sep 02, 2009 08:01 AM | ACAD, CMED, ETFC
- Stocks Fall at Mid-Day on Profit-Taking After Economic Data
Sep 01, 2009 01:50 PM | ACAD, AIG, ALU, BAC, EBAY, ICGN
- ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
Sep 01, 2009 06:00 AM | ACAD
- ACADIA Pharmaceuticals Reports Second Quarter 2009 Financial Results
Aug 05, 2009 04:10 PM | ACAD
- ACADIA Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 5, 2009
Jul 29, 2009 09:13 AM | ACAD
- ACADIA Pharmaceuticals to Present at the Eighth Annual Needham Life Sciences Conference on June 10, 2009
Jun 03, 2009 09:05 AM | ACAD
- ACADIA Pharmaceuticals to Present at the Eighth Annual JMP Securities Research Conference on May 19, 2009
May 13, 2009 09:15 AM | ACAD
- ACADIA Pharmaceuticals Reports First Quarter 2009 Financial Results
May 11, 2009 04:47 PM | ACAD
- ACADIA Pharmaceuticals and Biovail Announce Completion of Enrollment in First Pivotal Phase III Trial with Pimavanserin in Patients with Parkinson’s Disease Psychosis
May 06, 2009 08:26 AM | ACAD, BVF
- Biovail Reports First-Quarter 2009 Financial Results
May 06, 2009 07:53 AM | ACAD, BVF, WPI
- ACADIA Pharmaceuticals to Announce First Quarter 2009 Financial Results on May 11, 2009
May 05, 2009 10:02 AM | ACAD
- ACADIA Pharmaceuticals and Biovail Form Collaboration to Develop and Commercialize Pimavanserin in North America
May 04, 2009 07:39 AM | ACAD
- ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs
Mar 25, 2009 08:10 AM | ACAD
- Form 4 Tolf Bo-Ragnar For: Jul 08 (10K)
Jul 09, 2009 06:19 PM
- Form 4 WALTON ALAN G For: Jun 12 (10K)
Jun 16, 2009 05:55 PM
- Form 4 Binder Gordon M For: Jun 12 (10K)
Jun 16, 2009 05:37 PM
- Form 4 BORER MICHAEL T For: Jun 12 (10K)
Jun 16, 2009 05:37 PM
- Form 4 Brege Laura For: Jun 12 (10K)
Jun 16, 2009 05:37 PM
- Form 4 GRAY MARY ANN For: Jun 12 (10K)
Jun 16, 2009 05:35 PM
- Form 4 Iversen Leslie L For: Jun 12 (10K)
Jun 16, 2009 05:35 PM
- Form 4 KAPLAN LESTER J PH D For: Jun 12 (10K)
Jun 16, 2009 05:34 PM
- Form 4 Rasmussen Torsten For: Jun 12 (10K)
Jun 16, 2009 05:34 PM
- Form 4 Iversen Leslie L For: May 18 (10K)
May 20, 2009 05:41 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ACAD
|
Compare to S&P
|
| YTD |
44.44 %
|
25.91 %
|
| 4 Weeks |
-21.21 %
|
-22.05 %
|
| 12 Weeks |
-71.86 %
|
-72.56 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 15.00 %
|
|
EPS Growth in Last Year: 30.61 %
|
|
Sales Growth in Last Quarter: 386.63 %
|
|
Sales Growth in Last Quarter: 928.25 %
|
|
